Litigation
A Louisiana district court Sept. 30 upheld a state law prohibiting drug companies from denying Louisiana hospitals 340B discounts for drugs dispensed at community pharmacies.
The AHA Sept. 9 released a report highlighting how hospitals鈥 arrangements with community and specialty pharmacies improve access to care for underserved patients.
A district court in Baltimore Sept. 5 ruled against drug companies and PhRMA, denying their attempt to obtain a preliminary injunction against 340B pricing for contract pharmacy arrangements in Maryland, according to Reuters.
The AHA, 340B Health and the American Society of Health-System Pharmacists last week filed an amicus brief in a federal district court in Missouri, defending the state's law protecting 340B pricing for contract pharmacy arrangements.
If Johnson & Johnson moves forward with its plan to undermine the 340B Drug Pricing Program by unilaterally imposing a rebate model rather than the longstanding upfront discount model, the Health Resources and Services Administration should take 鈥渋mmediate enforcement action,鈥 including鈥
A Texas federal court Aug. 20 ruled set aside the Federal Trade Commission鈥檚 Non-Compete Clause Final Rule. U.S. District Judge Ada Brown held the FTC lacked the authority to enact the rule, which would ban, as an unfair method of competition, contractual terms that prohibit workers from pursuing鈥
While the AHA respects the FTC鈥檚 efforts to address issues of genuine unequal bargaining power between certain employers and certain types of workers, the FTC proposed non-compete rule would profoundly transform the health care labor market 鈥 particularly for physicians and senior hospital鈥
The AHA and the Federation of 黑料正能量s filed an amicus brief in a Texas federal court July 26, asking the court to vacate the Federal Trade Commission's Non-Compete Clause Final Rule.
A federal court in Texas last week found that the Federal Trade Commission likely lacked statutory authority to issue its Non-Compete Clause Final Rule.
The Supreme Court June 28 overturned a 1984 ruling in Chevron U.S.A., Inc. v. Natural Resources Defense Council, Inc., which required courts to defer to federal agencies to interpret ambiguous laws.